| Drug Name: | Xylazine (7361-61-7) |
|---|---|
| PubChem ID: | 5707 |
| SMILES: | CC1=C(C(=CC=C1)C)NC2=NCCCS2 |
| InchiKey: | BPICBUSOMSTKRF-UHFFFAOYSA-N |
| Therapeutic Category: | Adrenergic Agents, Adrenergic Agonists, Adrenergic alpha-2 Receptor Agonists, Adrenergic alpha-Agonists, Analgesics, Central Nervous System Agents, Central Nervous System Depressants, Hypnotics and Sedatives, Muscle Relaxants, Neuromuscular Agents, Neurotransmitter Agents, Peripheral Nervous System Agents, Sensory System Agents |
| Molecular Weight (dalton) | : | 220.341 |
| LogP | : | 3.20824 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 3 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 24.39 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category